Journal article
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
Leukemia & lymphoma, Vol.54(2), pp.290-297
02/01/2013
DOI: 10.3109/10428194.2012.711830
PMID: 22799432
Abstract
Quality of life (QoL) is an important outcome in patients with non-Hodgkin lymphoma (NHL). We assessed the validity of administering the Functional Assessment of Cancer Therapy - General (FACT-G) at 12-month intervals over 3 years in a longitudinal study of 611 prospectively enrolled, newly diagnosed patients with NHL. We evaluated corrected item-total correlation and percent missing to identify items that may be less useful in certain NHL patient subgroups. The FACT-G subscales and total score demonstrated good internal consistency reliability, convergent validity and known-groups validity. Most scores also demonstrated good responsiveness to change. Questions that could be problematic included GE3 (losing hope) and GP2 (nausea) for patients in remission, and GP5 (bothered by side effects) for patients being observed. Overall, the FACT-G was a valid measure for monitoring QoL over time in patients with NHL. However, sensitivity analyses based on subscale scoring that excludes potentially problematic items may be warranted.
Details
- Title: Subtitle
- The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
- Creators
- Kathleen J Yost - Department of Health Sciences ResearchCarrie A Thompson - Department of MedicineDavid T Eton - Department of Health Sciences ResearchCristine Allmer - Department of Health Sciences ResearchShawna L Ehlers - Department of Psychiatry and Psychology, Mayo Clinic, RochesterThomas M Habermann - Department of MedicineTait D Shanafelt - Department of MedicineMatthew J Maurer - Department of Health Sciences ResearchSusan L Slager - Department of Health Sciences ResearchBrian K Link - Department of Internal Medicine, College of Medicine, University of Iowa, Iowa CityJames R Cerhan - Department of Health Sciences Research
- Resource Type
- Journal article
- Publication Details
- Leukemia & lymphoma, Vol.54(2), pp.290-297
- DOI
- 10.3109/10428194.2012.711830
- PMID
- 22799432
- NLM abbreviation
- Leuk Lymphoma
- ISSN
- 1042-8194
- eISSN
- 1029-2403
- Publisher
- Taylor & Francis
- Language
- English
- Date published
- 02/01/2013
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984094534202771
Metrics
22 Record Views